(Q81560225)
Statements
Sequential administration of GM-CSF (Sargramostim) and IL-2 +/- autologous vaccine as adjuvant therapy in cutaneous melanoma: an interim report of a phase II clinical trial (English)
E George Elias
John L Zapas
Edward C McCarron
Sandra L Beam
Joanne H Hasskamp